FindTrial
Sign In

Comparing the Effect of Vaginal Misoprostol With Dinoprostone in Term Pregnancies

Status
UNKNOWN
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00432588
Enrollment
Unknown
Registered
2007-02-08
Start date
Unknown
Completion date
Unknown
Last updated
2007-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fetal Death, Fetal Membranes, Premature Rupture, Preeclampsia

Keywords

IUFD, POSTTERM, ROM

Brief summary

Hypothesis (H0): Labor duration and obstetric complications are not significantly different in the three groups (misoprostol-dinoprostone-oxytocin).

Interventions

DRUGmisoprostol
DRUGdinoprostone

Sponsors

Hormozgan University of Medical Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE

Inclusion criteria

* Term pregnancy * Singleton * Vertex * Bishop score below 6

Exclusion criteria

* History of drug reaction * Medical disease * IUGR * Oligohydramnios * Vaginal bleeding * Fetal anomaly * Uterine scar

Countries

Iran

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026